StonvexLoading…
StonvexStonvexStonvexCore line items from MCK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-03-31 | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $403.43B | $359.05B | $308.95B | $276.71B |
Operating Income | $6.21B | $4.42B | $3.91B | $4.38B |
Net Income | $4.76B | $3.29B | $3.00B | $3.56B |
EPS (Diluted) | $38.38 | $25.72 | $22.39 | $25.03 |
Total Assets | $82.32B | $75.14B | $67.44B | $62.32B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.98B | $5.69B | $4.58B | $4.68B |
Free Cash Flow OCF − CapEx | $5.72B | $5.55B | $3.88B | $4.77B |
Shares Outstanding | 124.10M | 128.10M | 134.10M | 142.20M |